310-598-5410investor.relations@opiant.com

News Releases

Error message

An illegal choice has been detected. Please contact the site administrator.

Year:

There are currently no news releases to display.

Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing treatments for substance use, addictive and eating disorders.

About Us
Science and Technology
Products and Pipeline
Investor Relations

Opiant Pharmaceuticals
201 Santa Monica Blvd., Suite 500
Santa Monica, CA 90401
PHONE: 310-598-5410
info@opiant.com
investor.relations@opiant.com